KPV Dosing & Reconstitution Guide
Dosing Protocol
Route: Oral (gut), Subcutaneous (systemic), Topical (skin) Frequency: 1-2 times daily Dose Range: Oral: 200-500 mcg/day; SC: 100-500 mcg/day; Topical: 0.01-0.1% preparation Cycle Length: 4-8 weeks Timing: Oral: before meals on empty stomach; SC: morning or evening
Storage
Lyophilized: -20 °C (-4 °F) Reconstituted: 2-8 °C (35.6-46.4 °F) Shelf Life: 21 days
Safety & Contraindications
Safety: No significant adverse effects reported in preclinical studies Does not cause skin darkening (unlike Melanotan peptides) No formal human safety trials have been conducted
Contraindications: Pregnancy and breastfeeding (no safety data); Known hypersensitivity to α-MSH-derived peptides; Immunosuppressed patients (theoretical — anti-inflammatory mechanism)
Related Products

KPV 10mg
10mg
Related Research News
KPV Peptide Research Guide: Synthesis, Uses and Lab Safety
KPV peptide, a tripeptide of lysine, proline and valine with formula C12H22N4O4, shows anti-inflammatory effects in studies on bowel disease and wound healing. Labs produce it mainly via solid-phase peptide synthesis, confirmed pure by HPLC and mass spectrometry. Proper storage, quality checks and regulatory compliance ensure reliable research outcomes.
Anti-Aging Peptides: Research Compounds for Metabolism, Muscle, and Tissue Health
Explore a curated selection of anti-aging research peptides including BPC-157, GHK-CU, KPV, MOTS-C, NAD+, Retatrutide, SS-31, TB-500, and others. These compounds are studied for their potential roles in metabolism support, muscle growth, weight loss, and skin, tissue, and bone health. Average purity across products is 99.77%.